1.
Fiorentino F, Di Rienzo P. Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy. Grhta [Internet]. 2023 Apr. 11 [cited 2024 Jul. 12];10(1):29-3. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2507